Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 9,521,793 $ 8,749,784 $ 16,492,799 $ 14,214,034
General and administrative 2,744,606 1,434,877 4,418,497 3,430,723
Total operating expenses 12,266,399 10,184,661 20,911,296 17,644,757
Loss from operations (12,266,399) (10,184,661) (20,911,296) (17,644,757)
Other income 536,743 67,632 937,267 179,825
Net loss $ (11,729,656) $ (10,117,029) $ (19,974,029) $ (17,464,932)
Net loss per share, basic (in dollars per share) $ (1.28) $ (7.26) $ (2.54) $ (12.53)
Net loss per share, diluted (in dollars per share) $ (1.28) $ (7.26) $ (2.54) $ (12.53)
Weighted-average outstanding Common Shares, basic (in shares) 9,142,366 1,394,048 7,874,562 1,394,048
Weighted-average outstanding Common Shares, diluted (in shares) 9,142,366 1,394,048 7,874,562 1,394,048